| The effect of cytochromes P4501A induction and inhibition on the disposition of the cognition activator tacrine in rat hepatic preparations. | |
| | |
MedLine Citation:
|
PMID: 8893040 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
1. The disposition of tacrine 1,2,3,4-tetrahydro-9-acridinamine monohydrochloride monohydrate (THA, Cognex), was studied using livers obtained from control, phenobarbital (PB), isosafrole (ISO), and 3-methycholanthrene (3-MC) treated rats. 2. Pretreatment of rats with PB, ISO, and 3-MC reduced AUC(10-120 min) of THA in liver perfusates by 28, 32, and 86% respectively. 3. Elimination of [14C]-THA-derived radioactivity into bile was 7.6 +/- 1.2%, 11.7 +/- 2.9%, 14.8 +/- 2.0%, and 46.3 +/- 9.7% (mean +/- SD) of the infusion dose for control PB, ISO, and 3-MC pretreated isolated perfused rat livers, respectively. 4. In perfusion experiments using 3-MC pretreated livers, a marked increase in irreversible protein binding of 3-, 7-, and 8-fold was observed to microsomal, cytosolic and total liver proteins, respectively, compared to control. Only a slight effect was observed on protein binding in perfusion experiments using PB and ISO pretreated animals. 5. Co-incubations of [14C]-THA with the metabolic inhibitors enoxacin, ethimizol, and furafylline in hepatocyte preparations obtained from 3-MC pretreated rats markedly inhibited THA-derived irreversible protein binding. Furafylline, a specific inhibitor of cytochrome P4501A2, had the greatest inhibitory effect (approximately 70%). 6. These results are consistent with a major role of cytochrome P4501A in the metabolism and irreversible protein binding of THA in rat liver and demonstrate the utility of isolated liver perfusion and hepatocyte models for examining the effect of metabolic modulators. |
| | |
Authors:
|
S Bezek; M Kukan; W F Pool; T F Woolf |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Xenobiotica; the fate of foreign compounds in biological systems Volume: 26 ISSN: 0049-8254 ISO Abbreviation: Xenobiotica Publication Date: 1996 Sep |
Date Detail:
|
Created Date: 1997-02-07 Completed Date: 1997-02-07 Revised Date: 2003-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 1306665 Medline TA: Xenobiotica Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 935-46 Citation Subset: IM |
Affiliation:
|
Pharmacokinetics and Drug Metabolism Department, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, MI 48106, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cholinesterase Inhibitors / metabolism* Chromatography, High Pressure Liquid Cytochrome P-450 CYP1A1 / metabolism* Cytochrome P-450 CYP1A2 / metabolism* Enoxacin / pharmacology Enzyme Induction Etimizol / pharmacology Glucuronidase / metabolism Glutathione / pharmacology Liver / drug effects, enzymology Male Methylcholanthrene / pharmacology Rats Rats, Wistar Tacrine / metabolism* Theophylline / analogs & derivatives, pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Cholinesterase Inhibitors; 321-64-2/Tacrine; 56-49-5/Methylcholanthrene; 58-55-9/Theophylline; 64-99-3/Etimizol; 70-18-8/Glutathione; 74011-58-8/Enoxacin; 80288-49-9/furafylline; EC 1.14.14.1/Cytochrome P-450 CYP1A1; EC 1.14.14.1/Cytochrome P-450 CYP1A2; EC 3.2.1.31/Glucuronidase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Metabolism of 14C-sulphadimethoxane in swine.
Next Document: Absorption and disposition of ranitidine hydrochloride in rat and dog.